Testosterone & GLP-1s: Can They Work Together?

The Truth About Weight Loss, Muscle Preservation & Hormone Health

LARAMIE PHYSICIANS WOMEN & WELLNESS CLINIC | THE TESTOSTERONE ESSENTIALS LIBRARY | VOLUME 04

Two conversations that often meet: losing weight and understanding testosterone.

A note on the story: Ryan is fictional, not a real patient or testimonial. This book does not recommend combining prescriptions or promise improved results from a combination.

1. The Scale Moved. Now What?
2. Two Systems, Two Different Jobs
3. The Hidden Question Behind Weight Loss
4. Does Losing Weight Change Testosterone?
5. Can TRT Protect Muscle During GLP-1 Treatment?
6. The Safety Conversation Comes First
7. Building a Muscle-Aware Weight-Loss Plan
8. Your Conversation Checklist
9. Sources & Further Reading

Chapter 01

The Scale Moved. Now What?

At 48, Ryan had stopped trusting his bathroom scale. It had barely budged through months of effort. After a medical evaluation, he started an approved GLP-1-based weight-management medication. His appetite shifted. The numbers on the scale began moving.

Then he noticed something that didn't fit the victory narrative: he was smaller, but he worried he was also weaker. On his phone he saw two very different claims. One post insisted that every man on a GLP-1 needed testosterone. Another insisted testosterone had nothing to do with weight loss. He suspected the truth was more complicated.

It was. The real question was not 'Should I stack these drugs?' It was 'How can I improve metabolic health while preserving function, strength, and good medical decision-making?'

Chapter 02

Two Systems, Two Different Jobs

GLP-1 is short for glucagon-like peptide-1, a hormone involved in appetite and blood-glucose regulation. Medicines such as semaglutide act on GLP-1 receptors; tirzepatide activates both GIP and GLP-1 receptors. Approved products have specific indications and precautions, and the suitability of a medication depends on the patient and the product. [1]

Testosterone is a sex hormone with roles in reproductive function, muscle, bone, and red blood cells. Testosterone replacement therapy is considered for appropriately evaluated testosterone deficiency, not prescribed simply because someone uses weight-loss medication. [2]

The overlap is understandable. Weight, sleep apnea, insulin resistance, and other health factors can influence testosterone levels, while losing substantial weight changes body composition. Yet these are separate medical decisions with separate criteria.

TWO DIFFERENT QUESTIONS: 'Do I meet criteria for obesity medication?' and 'Do I have confirmed testosterone deficiency?' One answer does not determine the other.

Chapter 03

The Hidden Question Behind Weight Loss

When Ryan's weight went down, he thought he was losing only fat. In reality, most meaningful weight loss involves changes in multiple tissues. Measurements of 'lean mass' include muscle and other non-fat components. Lean-mass changes do not translate one-to-one into lost muscle strength, but preserving function and adequate nutrition is important.

Current obesity-care guidance emphasizes resistance training, adequate protein tailored to individual needs, and attention to muscle strength and function while receiving GLP-1-based treatment. Activity plans should reflect age, medical conditions, experience, and mobility. [3]

A better progress dashboard might include how clothes fit, blood pressure, relevant laboratory results, strength, stamina, sleep, and how sustainable the plan feels. A number on a scale can be helpful without becoming the only definition of success.

Chapter 04

Does Losing Weight Change Testosterone?

Excess adiposity, especially when linked with metabolic dysfunction, can be associated with lower testosterone in men. Weight reduction may improve testosterone measurements in some men, depending on baseline health and the amount of weight lost. But an improvement in a laboratory value is not guaranteed for every person, and changes in testosterone do not themselves establish that TRT is needed.

Imagine two men losing weight. One began with low testosterone partly related to obesity and sees his levels rise after sustained weight loss. The other has a separate problem affecting testosterone production and continues to have consistently low levels and symptoms. Their appropriate next steps may be different.

For that reason, the timing of repeat testing and the interpretation of results should be individualized. A man who has concerns about libido, anemia, or other persistent symptoms should be evaluated rather than prescribed testosterone reflexively because he is losing weight.

Chapter 05

Can TRT Protect Muscle During GLP-1 Treatment?

This is the headline that attracts attention, but it requires careful language. Testosterone can influence body composition in men who have deficiency. It does not follow that adding TRT to a GLP-1 program has been proven to prevent muscle loss, improve long-term function, or produce better outcomes for all men.

There is active research interest in combining body-composition strategies with anti-obesity medicines. However, an automatic 'GLP-1 plus TRT' package should not be portrayed as an established muscle-preservation protocol. Diagnosis, independent indications, patient-specific risks, and outcomes still matter.

The best-supported foundation for protecting strength during weight loss remains physical activity that includes resistance exercise, individualized adequate protein and calorie intake, and ongoing assessment of function. [3][4]

THE EVIDENCE CHECK: 'Promising biological rationale' is not the same thing as 'proven clinical combination.'

Chapter 06

The Safety Conversation Comes First

GLP-1-based drugs may cause nausea, vomiting, diarrhea, constipation, and other gastrointestinal effects; relevant approved products carry serious warnings and contraindications, including boxed warnings about thyroid C-cell tumors in rodents and contraindications related to personal or family history of medullary thyroid carcinoma or MEN2. Patients need individualized review of their medication's current label. [1]

TRT has a separate risk and monitoring profile, including hematocrit, blood pressure, fertility considerations, and other health factors. Using two treatments does not remove the cautions of either one. [2][5]

Compounded products require extra scrutiny. FDA warns that unapproved versions of semaglutide and tirzepatide have not undergone its premarket review for quality, safety, and effectiveness; it has reported dosing errors and other concerns. The FDA states that compounded drugs should be used only when a patient's medical needs cannot be met by an FDA-approved drug. [6]

No one should modify doses or combine prescriptions based solely on a social media 'stack.' Clinicians must evaluate each proposed therapy independently and consider interactions, medical history, product source, and follow-up.

Chapter 07

Building a Muscle-Aware Weight-Loss Plan

Ryan's next appointment became more productive when he stopped asking for a magical combination and started asking about a complete plan.

He could discuss whether his weight-management medication was right for him; whether his food intake supplied adequate protein and nutrients; how to begin or continue resistance exercise; how to monitor dizziness, dehydration, or gastrointestinal problems; and whether his symptoms justified separate testosterone testing.

A practical weekly check-in can include:

• Nutrition: Can I meet an individualized protein and nutrition plan without severe nausea?
• Movement: Am I doing safe resistance exercise at a sustainable level?
• Function: Can I carry groceries, climb stairs, and perform my chosen exercises as well as before?
• Symptoms: Have sleep, sexual concerns, energy, or other symptoms changed?
• Medication safety: Do I understand my prescribed product, how to use it, and whom to call if problems develop?

Ryan began tracking something the scale couldn't measure: whether he was building a healthier life he could maintain.

Chapter 08

Your Conversation Checklist

Ask the prescribing clinician:

1. What are my individual goals beyond weight loss?
2. What strength, function, and nutritional measures should we follow?
3. What GLP-1 risks and contraindications apply to me?
4. If I have symptoms of low testosterone, do I need independent morning testing?
5. Is TRT actually indicated in my case - and what evidence would support it?
6. Who monitors each treatment, adverse effects, and relevant labwork?
7. What is the plan for maintaining weight and function over time?

Explore your options: Visit laramiephysicians.com to learn about clinician-guided weight management and testosterone evaluation. These services have separate indications; no combination is guaranteed or necessarily appropriate.

Chapter 09

Sources & Further Reading

[1] FDA prescribing information for Wegovy (semaglutide). https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218316Orig1s000lbl.pdf

[2] Endocrine Society. Testosterone Therapy for Hypogonadism Guideline Resources. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy/

[3] American Diabetes Association. Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity (2026). https://doi.org/10.2337/doci25-0008

[4] Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1-based therapies (expert consensus, 2025). https://pmc.ncbi.nlm.nih.gov/articles/PMC12768930/

[5] U.S. FDA. Testosterone Information (2026 update). https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/testosterone-information

[6] U.S. FDA. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (2026). https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

Medical editorial note: Educational draft prepared October 19, 2026. Physician and advertising-compliance review required. Do not represent testosterone plus GLP-1 therapy as a proven universal combination.